Brian Edward Miller Sells 8,900 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Brian Edward Miller sold 8,900 shares of the stock in a transaction on Tuesday, March 11th. The stock was sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the completion of the sale, the executive vice president now directly owns 5,758 shares of the company’s stock, valued at $2,793,033.06. The trade was a 60.72 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

Intuitive Surgical Stock Performance

Intuitive Surgical stock opened at $484.44 on Friday. The firm’s 50-day moving average is $567.46 and its 200-day moving average is $531.26. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00. The company has a market cap of $172.55 billion, a P/E ratio of 75.58, a PEG ratio of 5.85 and a beta of 1.43.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of ISRG. Howard Capital Management Group LLC lifted its position in shares of Intuitive Surgical by 4.5% in the 3rd quarter. Howard Capital Management Group LLC now owns 2,125 shares of the medical equipment provider’s stock worth $1,044,000 after buying an additional 92 shares during the last quarter. Principal Financial Group Inc. increased its holdings in shares of Intuitive Surgical by 1.5% in the 3rd quarter. Principal Financial Group Inc. now owns 602,393 shares of the medical equipment provider’s stock worth $295,938,000 after acquiring an additional 9,194 shares during the period. Meritage Portfolio Management acquired a new stake in shares of Intuitive Surgical in the 3rd quarter worth about $210,000. Venturi Wealth Management LLC increased its holdings in shares of Intuitive Surgical by 166.5% in the 3rd quarter. Venturi Wealth Management LLC now owns 1,351 shares of the medical equipment provider’s stock worth $664,000 after acquiring an additional 844 shares during the period. Finally, Nations Financial Group Inc. IA ADV increased its holdings in shares of Intuitive Surgical by 13.7% in the 3rd quarter. Nations Financial Group Inc. IA ADV now owns 786 shares of the medical equipment provider’s stock worth $386,000 after acquiring an additional 95 shares during the period. 83.64% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

ISRG has been the subject of several recent research reports. JPMorgan Chase & Co. increased their price objective on shares of Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. Jefferies Financial Group increased their price objective on shares of Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. Piper Sandler restated an “overweight” rating and issued a $670.00 target price (up from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. Wells Fargo & Company upped their target price on shares of Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. Finally, Raymond James upped their target price on shares of Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a research note on Friday, January 24th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and sixteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and an average target price of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.